CN101748128A - Schistosoma japonica titin gene and coding protein and application thereof - Google Patents

Schistosoma japonica titin gene and coding protein and application thereof Download PDF

Info

Publication number
CN101748128A
CN101748128A CN200810044092A CN200810044092A CN101748128A CN 101748128 A CN101748128 A CN 101748128A CN 200810044092 A CN200810044092 A CN 200810044092A CN 200810044092 A CN200810044092 A CN 200810044092A CN 101748128 A CN101748128 A CN 101748128A
Authority
CN
China
Prior art keywords
titin
schistosoma
schistosoma japonica
japonica
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810044092A
Other languages
Chinese (zh)
Inventor
刘锋
韩泽广
冯正
胡薇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese National Human Genome Center at Shanghai
Shanghai Human Genome Research Center
Original Assignee
Shanghai Human Genome Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Human Genome Research Center filed Critical Shanghai Human Genome Research Center
Priority to CN200810044092A priority Critical patent/CN101748128A/en
Publication of CN101748128A publication Critical patent/CN101748128A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a schistosoma japonica titin gene and a coding protein and an application thereof. The schistosoma japonica titin gene comprises a nucleotide sequence shown by SEQ ID No. 1; schistosoma japonica titin comprises a protein with a nucleotide sequence shown by SEQ ID No. 2 or a protein with the same function formed by replacing and deleting or inserting the protein; and the protein is provided with a SEQ ID No. 1 sequence code. The schistosoma japonica titin is applied to schistosome vaccine preparation as an immunogen, chemical and other types medicament screening as a potential medicament action target spot and anti-schistosoma antibody preparation as a specific schistosome antigen as well as serodiagnosis; and the schistosoma japonica actin gene is applied to gene therapy.

Description

Schistosoma japonica titin gene, its proteins encoded and application
Technical field
The present invention relates to a kind of connetin, particularly relate to a kind of Schistosoma japonica titin gene, its proteins encoded and application.
Background technology
Schistosomicide is caused that by bilharzial infection 76 countries are arranged in the world, and the sufferer about 1.5 hundred million.Morbific schistosomicide has 3 kinds, both Schistosoma japonicum (Schistosoma japonicum), Schistosoma mansoni (S.mansoni) and Schistosoma haematobium (S.haematobium).At China's popular is Schistosoma japonicum.The popular of schistosomicide all causes tremendous loss for people's health and Economic development, and therefore, prevention and cure of schistosomiasis, development schistosomicide reagent for clinical diagnosis and antischistosomal medicine have huge social and economic benefit.
Can there be a lot of years in Schistosoma japonicum as parasite and not be killed by host's immunologic mechanism in human body and animal body, relevant with its immune evasion ability.Its immune evasion mechanism has antigen mimicking, antigen camouflage and immunomodulatory.Wherein immunomodulatory refers to the immunity system that (mainly being to suppress) host can be regulated, be disturbed to bilharzial albumen, makes its immune attack usefulness that can not bring into normal play, thereby helps bilharzial existence.
(Excretory/Secretory protein ESP) is exactly the protein that a class can be brought into play immunoregulation effect to bilharzial drainage/secretion antigen.These albumen are from bilharzial epidermis and gut epithelium, or the drainage/secretory of specialization.Each worm phase of schistosomicide all produces this proteinoid.ESP is potential drug target spot and vaccine molecule, thereby can disturb bilharzial immune evasion mechanism enhancing host's immunity to kill function because suppress these albumen; ESP is a potential diagnosis molecule, because these albumen are free in host's the blood, can detect with existing means easily.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Schistosoma japonica titin gene, its proteins encoded and application, and this albumen can become the target molecules of schistosomicide clinical diagnosis.
For solving the problems of the technologies described above, the gene of Schistosoma japonica titin of the present invention comprises: have the nucleotide sequence shown in the SEQ IDNO.1.
Nucleotide sequence coded albumen shown in the described SEQ ID NO.1 with sequence shown in the SEQ ID NO.2.
Schistosoma japonica titin of the present invention comprises:
Have the albumen of aminoacid sequence shown in the SEQ ID NO.2 or one or more amino acid whose displacements, disappearance or insertion take place and the albumen with identical function that forms by this albumen, this albumen is the albumen with SEQ ID NO.1 sequence encoding.
Utilize the proteomics means, we have analyzed the moiety of ESP of the vitro extraction of Schistosoma japonicum in the world first.We find that the connetin (Titin) of Schistosoma japonicum is one of main component of its ESP, show that this albumen may play a significant role aspect bilharzial immunomodulatory, the immune evasion; Simultaneously, by the blood of direct analysis infection animal (rabbit), find that this albumen also exists really in host's blood, this also makes it become good diagnostic flag molecule.
Schistosoma japonica titin of the present invention is as immunogen, the application aspect the preparation blood fluke vaccine; As the potential drug target, the application aspect screening chemistry and other kind medicines; As the specificity schistosome antigen, the application aspect preparation schistosomicide antibody; Application aspect serodiagnosis; The encoding gene of Schistosoma japonica titin, the application aspect gene therapy.
Embodiment
One, method:
1, proteic separation of Schistosoma japonicum excretion and identification experiment
1). the preparation and the protein extraction of Schistosoma japonicum adult excretion product:
Schistosoma japonicum adult is separated the back in the infection animal body and is washed 2 times with 1 * PBS (phosphate buffered saline buffer), and about 800 adults suspend with 1ml PBS, and low-speed centrifugal (500rpm) is collected the supernatant sucking-off after 10 minutes, repeats 10 volumes, and supernatant is merged.With the albumen in the acetone precipitation supernatant, dissolution precipitation 50mM Tris-HCl (pH 8.3), 5mM EDTA, 1mM phenylmethyl sulfonylfluoride (PMSF), 0.5%sodium dodecylsulfate (SDS) and 0.5mM DTT, 0.5%SDS, ultrasonic short molten.
2). the proteic enzymolysis process of Schistosoma japonicum excretion:
The excretion egg white mixture spends the night with the pancreatin enzymolysis with the iodacetyl ammonia treatment of 10mM DTT and 55mM, dilution back.
3). the on-line chromatograph of Schistosoma japonicum excretion proteolysis peptide section separates and mass spectrum is identified:
The peptide mixt that enzymolysis produces pumps 30 μ l with vacuum with liquor capacity.Afterwards, on the peptide mixt of each component sample to anti-phase catch post (C18,5 μ m,
Figure G2008100440928D0000021
300 μ m i.d * 5mm, LC Packings), desalination under the flow velocity of 20 μ l/min.This 75 μ m * 150mm C18 post (LC Packings) of catching post and an analysis usefulness is connected then, just under the flow velocity of 200nl/min, wash-out enters the QSTAR pulser i of the electric spray ion source that Protana NanoES is housed peptide mixt from this pillar.Agilent 1100 capillary liquid phase systems (Agilent Technologies) are used to provide mobile phase A (0.5% acetic acid/water) and Mobile phase B (0.5% acetate/acetonitrile), linear gradient be in 60 minutes 5%B to 50%B, 50%B is to stop 15 minutes at 90%B to 90%B then in 30 minutes.The PicoTip that connects a 10-μ m diameter by one stainless two logical (Valco Instrument) behind analytical column receives fog-spray nozzle (New Objective), adds the spray voltage of 2500-3000 volt, to obtain stable spraying.MS/MS tandem mass spectrum spectrogram comes record by collection (IDA) and the task-circulation enhancing that information relies on.Measure in the scanning at each, choose 3-6 signal the strongest, with the ion of 2 to 3 electric charges, smash with the rolling collision energy, with the information of acquisition tandem mass spectrum.
4). the proteic software search of Schistosoma japonicum excretion is identified:
The database of mass spectrum search usefulness comprises the Schistosoma japonicum protein sequence of downloading from public database NCBI from 11717 (time is on October 16th, 2008).Search software is MASCOT (http://www.matrixscience.com/, Matrix Science).Search parameter is: maximum leakage point of contact, 3; Monoisotopic; The peptide charge number ,+1/+2/+3; Modify halfcystine carbamoylmethylation and methionine oxidation.After Search Results merges, carry out filtering screening: 1. to the search result list of each tandem mass spectrum spectrogram, only extract the result of ranking, other then abandon at first with following standard; 2. if in the peptide section that search obtains KR is arranged, KK, RK, sequences such as RR, then this peptide section abandons; 3. search for the peptide section that obtains, length is 8 reservations more than the amino acid, less than 8 amino acid whose abandoning; 4. repeat the peptide section got to, only calculate that wherein score value is the highest, these peptide section score values are added up, as proteic score; 5. proteic score surpasses 60, just thinks believable result.The low albumen that divides keeps after manual the inspection or abandons.Match host or bovine trypsin, keratic peptide section, then abandon.
Carry out the search of reverse protein sequence library simultaneously.Oppositely protein pool is with the counter-rotating of Schistosoma japonicum protein sequence, keep length, form constant.According to forward storehouse and the result that reverse library searching obtains, determine false positive rate.Method of calculation: false positive=2* (oppositely storehouse peptide hop count)/(forward storehouse peptide hop count+reverse storehouse peptide hop count).False positive is controlled at 0%.
2, the excretion albumen of direct analysis Schistosoma japonicum from infection animal serum
1. schistosoma japonicum cercariae infects rabbit, collects and infects the 42nd day the animal serum in back.Form with the liquid chromatography-mass spectrography analysing protein behind the serum protein enzymolysis.The Protein Data Bank of mass-spectrometric data search Schistosoma japonicum is according to above-mentioned standard screening peptide section.The peptide section that obtains is removed the peptide section of any coupling with the genes database (comprising mRNA, EST, gene order-checking data etc.) of Blast search rabbit, and the peptide section that remains all is that schistosomicide is distinctive.Utilize the peptide section then, search obtains corresponding schistosomicide protein sequence.
2. albumen abundance quantitative analysis: (Spectra count SC), represents the abundance height with this to calculate the mass spectrum sum that each Identification of Fusion Protein obtains.
Two, result
1) the proteic proteomics qualification result of the external excretion of Schistosoma japonicum
Identify 110 schistosomicide albumen altogether.Wherein connetin is one of higher albumen of relative abundance, and the SC sum is 32, and peptide section score summation is 1736, identifies this proteic 5 kinds of peptide sections (table 1) altogether.This explanation, connetin is one of main protein ingredient in the Schistosoma japonicum adult excretion product.Adult is in host (as the people) body, and its excretion product must be discharged in host's the blood circulation system, therefore, detects the existence of schistosomicide excretion product, just can detect schistosomicide.And the high albumen of abundance in the excretion product, the easiest being detected, therefore, connetin is suitable clinical diagnosis molecule, can utilize existing universal method such as ELISA to detect schistosomicide characteristic protein in patient's blood sample easily.
The mass spectrum qualification result in external excretion protein groups of table 1 Schistosoma japonica titin
Figure G2008100440928D0000041
2) we directly identify the excretion albumen of Schistosoma japonicum in the world first from infected animal serum.Identify a kind of peptide section (table 2) of connetin, proved that the connetin of Schistosoma japonicum is present in the serum of host animal really, can be detected, thereby can become the target molecules of schistosomicide clinical diagnosis.
The qualification result of table 2 Schistosoma japonica titin in infection animal serum
Figure G2008100440928D0000042
Sequence table
<110〉Research Center of Shanghai Human Genome
<120〉Schistosoma japonica titin gene, its proteins encoded and application
<130>NP-08-12792
<160>2
<170>PatentIn?version?3.3
<210>1
<211>3325
<212>RNA
<213〉Schistosoma japonicum (Schistosoma japonicum)
<400>1
cctttttagt?tgataaatta?aattaaaatt?tgaggtttat?tggtaataat?ataatgtcaa 60
ctgtagctat?gccagcaact?gtttttcaag?catctactcc?tggaaatcct?ccacaaattt 120
taagtccatt?atgtggtggc?ggtgaagttc?cagaaggaga?acctgttcat?ttagaattac 180
gaattgatcc?tccaggtgat?ttgcaggtac?aatggtttaa?agatggtgtt?gcattaagtg 240
caggttctcg?ttacaatact?atgtgtgaac?gtggtttagc?ctcattggat?gtaatatata 300
caatccagga?agacagtggt?acctattttt?gtgtgatatc?gaatccatat?ggacatgctc 360
aaagtgaagc?agttcctgtg?aatgttatac?ctgaaattga?tccaaatcaa?gatcatttag 420
atgcacaatt?tgctgatcta?tatcaagcaa?ctagtgcacc?tataaaagaa?tatgaacgtg 480
atcagagaag?tcagccaaag?agtgcaccac?aattttctca?gcaaccggtg?attagtagta 540
gtgatgttct?tgaaggtgaa?cctgtgagaa?tggaggcata?cttaaatacg?acaggtgatt 600
caacactaca?agttgattgg?atgaaaaatg?gacaaccagt?tggtacagga?agtcgtttta 660
acgccatcct?tgatagaggt?ttagttgtcc?tggaaattgg?ttattgtctg?gtcgatgata 720
gtggattgta?tgtttgtgta?gctacaaatg?cacttggacg?cacagagagc?caacctgtgg 780
aactaagatg?ccaaccagaa?gaacgaattg?ttactacctc?tatcctggat?cagcaatcaa 840
taaatcattt?gaagcaatta?gaggaaccag?gagaagattt?cgatcatagt?gccaatgcaa 900
caattcaagg?tatatcccca?tctttcaagg?ccaatttaga?acctgctacg?gttcaagtta 960
atgaggatga?acctgtaatt?ttctccgtac?cggttgactg?tggaaatgga?gatcacgtgg 1020
ttattgagtg?gaaacgtgat?ggtcaggttg?ttaaaacagg?atctcgaatc?actggaagtt 1080
tagagcttgg?aatagccagc?ttaaaaattc?attatgccca?gccgaatgat?actggagcat 1140
acacttgtca?tatttctaca?gaatatggat?cagctgactg?tggtccatcc?aacttattat 1200
gtgaagctac?tggtagtata?atcgctgcaa?gccaacttcc?aggtgacaaa?gaaaaaggtc 1260
tactagcgat?tgaagcgata?gaagcgaatt?tgcatgcacc?acgcggtaca?gtatgggaag 1320
atgaaagtcc?acatgaagca?cctgttatta?ttcaacaacc?acaatctgtt?ggtgaaattg 1380
aggaaggaac?agccattcat?tttgatgttc?aggtagaacc?cgcttctgat?ccttcactta 1440
ttgttgaatg?gtttaaaagt?ggcaatttat?taacaagtgg?aacaagattc?aaagttgcat 1500
atgatagagg?attagccact?ctagatattt?tgtatactat?tcctgaagat?agcggtgaat 1560
attggtgccg?tgtagagaat?aaagctggtc?aaatggaaag?taatcatgta?caagttttat 1620
gtaacgccag?tgcgtctgta?atcacacaca?gtaatctttt?acaaggtaca?gagggctaca 1680
atttaataaa?agctattgaa?gaagttgaac?agattgacgg?agatgaatat?agatacatag 1740
aggacgaaga?ggttgattca?gctcctcatt?ttgatgtcaa?gcctcaagca?gctactatag 1800
gtgaaggttc?cccagttaaa?tttttagtac?gtgttagtgg?taaaccaaca?ccacagctta 1860
cttggtatct?caatgacgaa?ccaattgaac?aagattcgat?tacgaaaatc?tatagtgatg 1920
gtgcaataaa?ttacttagaa?atgagtcgtt?gccatgcttt?acaaggaact?aataagctac 1980
atgttattgc?acaaaatcaa?ttaggaaaag?ctgaagctga?aacggttctt?acagttgtat 2040
tggcggaaga?tttcagaccg?gatttaaaac?atgttaaacc?agaaaatcct?tacaaaaaga 2100
tggttggatt?acgtaaagta?gactgttcac?cagaattaaa?taaagcgtta?acgagaacta 2160
aaccgtctgc?tcaaacaatt?ttagaaatgg?aaagaggttc?tgaaatgaaa?gctcgtactt 2220
atcgttcacc?agaggtagtc?gaggcagaga?aaatgttgga?tcaacttgct?tcgagtttaa 2280
gaaaatctga?acttaaacga?ccattggtaa?atggtagcca?tcaaaatgat?gcagcataac 2340
ctattcacat?agcattgaaa?tgcattacta?ttcatactta?aatcaaatat?ctacttgatt 2400
attctatttc?ccaatgttta?tttactgaac?aaacaattaa?acttttgtgc?ttccaaatat 2460
aaaaaaaaaa?gattataaac?ataaatgatg?aaatatcaaa?cattaattgt?tttattatca 2520
catgtttaca?tttatattct?ttgcttttaa?atgaaattta?tcagtttcta?tcatttaatc 2580
aatagtttct?tttaataata?cttatttcag?aacatttatt?taaatgatga?tatatgactt 2640
tgaaataaat?tttattattc?attactgaat?aatacaatgg?taatgatgaa?tgcattcatt 2700
acttgtaatc?tgatccgata?cttttcttta?ttcttagaat?tctttggttg?cttatattca 2760
gtcaattaca?tttgtttgtt?tatgtgtagt?ttttgtttct?tgatttaaaa?aaaaatgttt 2820
attacttacc?gatgaaatta?attcagtact?actattatta?tgaaatgaaa?attgaatcta 2880
tacttcatat?tataacttaa?taattaatat?ctaaatgata?attcaaacca?tttgtgaata 2940
actgaatgaa?tgaaaaatta?aattacttaa?ttttaatgac?aatatttatg?ttattacaat 3000
gttatccccc?attttatgga?tattgcatta?tttaaaatgt?tcaatttatg?ctgttatatt 3060
gtttatttaa?cagttcacct?ttaaatctac?ttttattcat?gaagaaaaaa?caaaagaaga 3120
tagaatacat?tatcatcagt?ataaaaatat?aaatcattta?ttgaatatgt?atcactggtt 3180
acaatgattc?ataccttaaa?gatcataatt?aagcattcta?aatgtgttag?ggattctttc 3240
tattatattc?tgtaacagta?aattatacac?taaggctatc?atacaaagta?tatacttgta 3300
ttattatgaa?aaaaaaaaaa?aaaaa 3325
<210>2
<211>761
<212>PRT
<213〉Schistosoma japonicum (Schistosoma japonicum)
<400>2
MSTVAMPATV?FQASTPGNPP?QILSPLCGGG?EVPEGEPVHL?ELRIDPPGDL?QVQWFKDGVA 60
LSAGSRYNTM?CERGLASLDV?IYTIQEDSGT?YFCVISNPYG?HAQSEAVPVN?VIPEIDPNQD 120
HLDAQFADLY?QATSAPIKEY?ERDQRSQPKS?APQFSQQPVI?SSSDVLEGEP?VRMEAYLNTT 180
GDSTLQVDWM?KNGQPVGTGS?RFNAILDRGL?VVLEIGYCLV?DDSGLYVCVA?TNALGRTESQ 240
PVELRCQPEE?RIVTTSILDQ?QSINHLKQLE?EPGEDFDHSA?NATIQGISPS?FKANLEPATV 300
QVNEDEPVIF?SVPVDCGNGD?HVVIEWKRDG?QVVKTGSRIT?GSLELGIASL?KIHYAQPNDT 360
GAYTCHISTE?YGSADCGPSN?LLCEATGSII?AASQLPGDKE?KGLLAIEAIE?ANLHAPRGTV 420
WEDESPHEAP?VIIQQPQSVG?EIEEGTAIHF?DVQVEPASDP?SLIVEWFKSG?NLLTSGTRFK 480
VAYDRGLATL?DILYTIPEDS?GEYWCRVENK?AGQMESNHVQ?VLCNASASVI?THSNLLQGTE 540
GYNLIKAIEE?VEQIDGDEYR?YIEDEEVDSA?PHFDVKPQAA?TIGEGSPVKF?LVRVSGKPTP 600
QLTWYLNDEP?IEQDSITKIY?SDGAINYLEM?SRCHALQGTN?KLHVIAQNQL?GKAEAETVLT 660
VVLAEDFRPD?LKHVKPENPY?KKMVGLRKVD?CSPELNKALT?RTKPSAQTIL?EMERGSEMKA 720
RTYRSPEVVE?AEKMLDQLAS?SLRKSELKRP?LVNGSHQNDA?A 761

Claims (8)

1. the gene of a Schistosoma japonica titin is characterized in that: comprising: have the nucleotide sequence shown in the SEQ ID NO.1.
2. the gene of Schistosoma japonica titin as claimed in claim 1 is characterized in that: the albumen of sequence shown in the nucleotide sequence coded SEQ of the having ID NO.2 shown in the described SEQ IDNO.1.
3. Schistosoma japonica titin comprises: have the albumen of aminoacid sequence shown in the SEQ ID NO.2 or one or more amino acid whose displacements, disappearance or insertion take place and the albumen with identical function that forms by this albumen.
4. the application of Schistosoma japonica titin aspect the preparation blood fluke vaccine.
5. the application of Schistosoma japonica titin aspect screening of medicaments.
6. the application of Schistosoma japonica titin aspect preparation schistosomicide antibody.
7. the application of Schistosoma japonica titin aspect serodiagnosis.
8. a Schistosoma japonica titin utilizes its encoding gene, the application aspect gene therapy.
CN200810044092A 2008-12-11 2008-12-11 Schistosoma japonica titin gene and coding protein and application thereof Pending CN101748128A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810044092A CN101748128A (en) 2008-12-11 2008-12-11 Schistosoma japonica titin gene and coding protein and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810044092A CN101748128A (en) 2008-12-11 2008-12-11 Schistosoma japonica titin gene and coding protein and application thereof

Publications (1)

Publication Number Publication Date
CN101748128A true CN101748128A (en) 2010-06-23

Family

ID=42475741

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810044092A Pending CN101748128A (en) 2008-12-11 2008-12-11 Schistosoma japonica titin gene and coding protein and application thereof

Country Status (1)

Country Link
CN (1) CN101748128A (en)

Similar Documents

Publication Publication Date Title
Sun et al. Molecular characterization of a putative serine protease from Trichinella spiralis and its elicited immune protection
BR112020003354A2 (en) preparation of therapeutic exosomes using membrane proteins
Huang et al. Identification and characterization of hADSC‐derived exosome proteins from different isolation methods
CN1953988B (en) Peptides derived from human BPLP protein, polynucleotides coding for the peptides and antibodies directed against the peptides
US20200188471A1 (en) Application of selective tnfr1 antagonist peptide sn10 in preparation of drugs for preventing and treating rheumatoid arthritis
WO2021233885A1 (en) Mimotope peptides of the spike protein from the sars-cov-2 virus
Babaei-Jadidi et al. Mast-cell tryptase release contributes to disease progression in lymphangioleiomyomatosis
EP3279325A1 (en) Nucleic acid aptamer capable of bonding to vascular endothelial growth factor receptor
JPH09511747A (en) Pharmaceutical composition for treating cedar pollen allergy
CN101748127A (en) Schistosoma japonica actin gene and a coding protein and application thereof
Diao et al. Cathepsin C (CTSC) contributes to the antibacterial immunity in golden pompano (Trachinotus ovatus)
CN102088992A (en) Peptidyl diacylglycerides
Mendonça et al. Upregulation of the vascular endothelial growth factor, Flt-1, in rat hippocampal neurons after envenoming by Phoneutria nigriventer; age-related modulation
CN101748140A (en) Schistosoma japonica glyceraldehyde-3-phosphate dehydrogenase gene and encoded protein and application thereof
CN101748138A (en) Schistosoma japonica superoxide dismutase gene and a coding protein and application thereof
CN101748139A (en) Schistosoma japonica enolase gene and coding protein and application thereof
Chen et al. Therapeutic efficacy of a Trichinella spiralis paramyosin-derived peptide modified with a membrane-targeting signal in mice with antigen-induced arthritis
CN101748128A (en) Schistosoma japonica titin gene and coding protein and application thereof
CN101921768A (en) Schistosoma japonica 14-3-3 protein gene, coded protein thereof and application thereof
CN101857634B (en) Activator protein for fibrinolytic system
CN101747422A (en) Schistosoma japonica fatty acid-binding protein and coding gene and application thereof
CN101921767A (en) Schistosoma japonica MF3 protein gene, and coding protein and application thereof
JPS62228023A (en) Immunological amplifier and related composition
CN101921783A (en) Schistosoma japonica L-lactic dehydrogenase gene, encoding protein and application thereof
CN101921782A (en) Schistosoma japonica arginyl transport RNA enzyme gene, encoding protein and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100623